PURPOSE: Standards for estimating maximal HR are important when interpreting the adequacy of physiologic stress during exercise testing, assessing chronotropic response, and prescribing an exercise training regimen. The equation 220 - age is used to estimate maximum HR; however, it overestimates measured maximal HR in patients taking β-adrenergic blockade (βB) therapy. This study developed and validated a practical equation to predict maximal HR in patients with heart failure (HF) taking βB therapy. METHODS: Data from symptom-limited exercise tests completed on patients with systolic HF participating in the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training trial and taking a βB agent were used to develop a simplified equation, which was validated using bootstrapping. RESULTS: The simplified derived equation was 119 + 0.5 (resting HR) - 0.5 (age) - (0, if test was completed using a treadmill; 5, if using a stationary bike). The R2 and SEE were 0.28 and 18 beats·min(-1), respectively. Validation of this equation yielded a mean R and SEE of 0.28 and 18 beats·min(-1), respectively. For the equation 220 - age, the R2 was -2.93, and the SEE was 43 beats·min(-1). CONCLUSIONS: We report a valid and simple population-specific equation for estimating peak HR in patients with HF taking βB therapy. This equation should be helpful when evaluating chronotropic response or assessing if a maximum effort was provided during exercise testing. We caution, however, that the magnitude of the variation (SEE = 18 beats·min(-1)) associated with this prediction equation may make it impractical when prescribing exercise intensity.
RCT Entities:
PURPOSE: Standards for estimating maximal HR are important when interpreting the adequacy of physiologic stress during exercise testing, assessing chronotropic response, and prescribing an exercise training regimen. The equation 220 - age is used to estimate maximum HR; however, it overestimates measured maximal HR in patients taking β-adrenergic blockade (βB) therapy. This study developed and validated a practical equation to predict maximal HR in patients with heart failure (HF) taking βB therapy. METHODS: Data from symptom-limited exercise tests completed on patients with systolic HF participating in the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training trial and taking a βB agent were used to develop a simplified equation, which was validated using bootstrapping. RESULTS: The simplified derived equation was 119 + 0.5 (resting HR) - 0.5 (age) - (0, if test was completed using a treadmill; 5, if using a stationary bike). The R2 and SEE were 0.28 and 18 beats·min(-1), respectively. Validation of this equation yielded a mean R and SEE of 0.28 and 18 beats·min(-1), respectively. For the equation 220 - age, the R2 was -2.93, and the SEE was 43 beats·min(-1). CONCLUSIONS: We report a valid and simple population-specific equation for estimating peak HR in patients with HF taking βB therapy. This equation should be helpful when evaluating chronotropic response or assessing if a maximum effort was provided during exercise testing. We caution, however, that the magnitude of the variation (SEE = 18 beats·min(-1)) associated with this prediction equation may make it impractical when prescribing exercise intensity.
Authors: Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith Journal: J Am Coll Cardiol Date: 2002-10-16 Impact factor: 24.094
Authors: C Maack; T Elter; G Nickenig; K LaRosee; M Crivaro; A Stäblein; H Wuttke; M Böhm Journal: J Am Coll Cardiol Date: 2001-10 Impact factor: 24.094
Authors: W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley Journal: Circulation Date: 1989-08 Impact factor: 29.690
Authors: Daniel E Forman; Robert Clare; Dalane W Kitzman; Stephen J Ellis; Jerome L Fleg; Toni Chiara; Gerald Fletcher; William E Kraus Journal: Am Heart J Date: 2009-10 Impact factor: 4.749
Authors: Renske Meijer; Martijn van Hooff; Nicole E Papen-Botterhuis; Charlotte J L Molenaar; Marta Regis; Thomas Timmers; Lonneke V van de Poll-Franse; Hans H C M Savelberg; Goof Schep Journal: Int J Gen Med Date: 2022-04-05
Authors: Daniela Dobre; Faiez Zannad; Steven J Keteyian; Susanna R Stevens; Patrick Rossignol; Dalane W Kitzman; Joel Landzberg; Jonathan Howlett; William E Kraus; Stephen J Ellis Journal: Eur Heart J Date: 2013-01-12 Impact factor: 29.983
Authors: Danylo F Cabral; Carrie A Hinchman; Christina Nunez; Jordyn Rice; David A Loewenstein; Lawrence P Cahalin; Tatjana Rundek; Alvaro Pascual-Leone; Joyce Gomes-Osman Journal: JMIR Res Protoc Date: 2021-11-23
Authors: Joshua R Smith; Jose R Medina-Inojosa; Veronica Layrisse; Steve R Ommen; Thomas P Olson Journal: J Clin Med Date: 2018-11-18 Impact factor: 4.241